User menu

Monitoring of urea and potassium by reverse iontophoresis in vitro.

Bibliographic reference Wascotte, Valentine ; Delgado-Charro, M Begoña ; Rozet, Eric ; Wallemacq, Pierre ; Hubert, Philippe ; et. al. Monitoring of urea and potassium by reverse iontophoresis in vitro.. In: Pharmaceutical research, Vol. 24, no. 6, p. 1131-7 (2007)
Permanent URL http://hdl.handle.net/2078.1/10905
  1. P. G. Green, M. Flanagan, B. Shroot, and R. H. Guy. Iontophoretic drug delivery. In K. A. Walters and J. Hadgraft (eds), Pharmaceutical Skin Penetration Enhancement, Dekker, New York, 1993, pp. 311–332.
  2. B. Leboulanger, R. H. Guy, and M. B. Delgado-Charro. Reverse iontophoresis for non-invasive transdermal monitoring. Physiol. Meas. 25:R35–R50 (2004).
  3. Y. N. Kalia, A. Naik, J. Garrison, and R. H. Guy. Iontophoretic drug delivery. Adv. Drug Deliv. Rev. 56:619–658 (2004).
  4. D. Marro, Y. N. Kalia, M. B. Delgado-Charro, and R. H. Guy. Contributions of electromigration and electroosmosis to iontophoretic drug delivery. Pharm. Res. 18:1701–1708 (2001).
  5. A. Sieg, R. H. Guy, and M. B. Delgado-Charro. Electroosmosis in transdermal iontophoresis: implications for noninvasive and calibration-free glucose monitoring. Biophys. J. 87:3344–3350 (2004).
  6. J. B. Phipps and J. R. Gyory. Trandermal ion migration. Adv. Drug Deliv. Rev. 9:137–176 (1992).
  7. R. R. Burnette and B. Ongpipattanakul. Characterization of the permselective properties of excised human skin during iontophoresis. J. Pharm. Sci. 76:765–773 (1987).
  8. M. J. Tierney, J. A. Tamada, R. O. Potts, R. C. Eastman, K. Pitzer, N. R. Ackerman, and S. J. Fermi. The GlucoWatch biographer: a frequent automatic and noninvasive glucose monitor. Ann. Med. 32:632–641 (2000).
  9. B. Leboulanger, J. M. Aubry, G. Bondolfi, R. H. Guy, and M. B. Delgado-Charro. Lithium monitoring by reverse iontophoresis in vivo. Clin. Chem. 50:2091–2100 (2004).
  10. I. T. Degim, S. Ilbasmis, R. Dundaroz, and Y. Oguz. Reverse iontophoresis: a non-invasive technique for measuring blood urea level. Pediatr. Nephrol. 18:1032–1037 (2003).
  11. N. K. Man, M. Touam, and P. Jungers. Causes et conséquences de l’urémie chronique, indications de la dialyse de suppléance. In L’Hémodialyse de Suppléance, Médecine-Sciences, Flammarion, Paris, 2003, pp. 1–15.
  12. A. Farkas, R. Vamos, T. Bajor, N. Mullner, A. Lazar, and A. Hraba. Utilization of lacrimal urea assay in the monitoring of hemodialysis: conditions, limitations and lacrimal arginase characterization. Exp. Eye Res. 76:183–192 (2003).
  13. R. Koncki, A. Radomska, and S. Glab. Bioanalytical flow-injection system for control of hemodialysis adequacy. Anal. Chim. Acta 418:213–224 (2000).
  14. T. A. Depner, P. R. Keshaviah, J. P. Ebben, P. F. Emerson, A. J. Collins, K. K. Jindal, A. R. Nissenson, J. M. Lazarus, and K. Pu. Multicenter clinical validation of an on-line monitor of dialysis adequacy. J. Am. Soc. Nephrol. 7:464–471 (1996).
  15. S. Alloatti, A. Molino, M. Manes, and G. M. Bosticardo. Urea rebound and effectively delivered dialysis dose. Nephrol. Dial. Transplant. 13(Suppl 6):25–30 (1998).
  16. L. R. Narasimhan, W. Goodman, and C. K. Patel. Correlation of breath ammonia with blood urea nitrogen and creatinine during hemodialysis. Proc. Natl. Acad. Sci. U. S. A. 98:4617–4621 (2001).
  17. Reviewing the draft NKF-DOQI guidelines. 1. National Kidney Foundation-Dialysis Outcome Quality Initiative. Nephrol. News Issues 11:10–11 (2000).
  18. G. S. Metry, P. O. Attman, P. Lonnroth, S. N. Beshara, and M. Aurell. Urea kinetics during hemodialysis measured by microdialysis—a novel technique. Kidney Int. 44:622–629 (1993).
  19. M. Capdevila, I. Martinez Ruiz, C. Ferrer, F. Monllor, C. Ludjvick, N. H. Garcia, and L. I. Juncos. The efficiency of potassium removal during bicarbonate hemodialysis. Hemodial. Int. 9:296–302 (2005).
  20. B. Redaelli, G. Bonoldi, G. Di Philippo, M. R. Vigano, and A. Malnati. Behaviour of potassium removal in different dialytic schedules. Nephrol. Dial. Transplant. 13:35–38 (1998).
  21. J. Ahmed and L. S. Weisberg. Hyperkaliemia in dialysis patients. Sem. Dial. 14:348–356 (2001).
  22. Pai Soo Hwan, Cyr-Manthey Marie, Effects of Hemolysis on Chemistry Tests, 10.1093/labmed/22.6.408
  23. D. Yücel and K. Dalva. Effect of in vitro hemolysis on 25 common biochemical tests. Clin. Chem. 38:575–577 (1992).
  24. M. J. Tierney, J. A. Tamada, R. O. Potts, L. Jovanovic, and S. Garg. Clinical evaluation of the GlucoWatch biographer: a continual, non-invasive glucose monitor for patients with diabetes. Biosens Bioelectron. 16:621–629 (2001).
  25. A. Sieg, R. H. Guy, and M. B. Delgado-Charro. Reverse iontophoresis for noninvasive glucose monitoring: the internal standard concept. J. Pharm. Sci. 92:2295–2302 (2003).
  26. A. Sieg, R. H. Guy, and M. B. Delgado-Charro. Simultaneous extraction of urea and glucose by reverse iontophoresis in vivo. Pharm. Res. 21:1805–1810 (2004).
  27. N. G. Levinsky. Fluides et Electrolytes. In J. D. Wilson, E. Braunwald, K. J. Isselbacher, R. G. Petersdorf, J. B. Martin, A. S. Fauci, and R. K. Root (eds), T.R. Harrison, Principes de Médecine Interne, Médecine-Sciences, Flammarion, Paris, 1992, pp. 278–295.
  28. B. Kirschbaum. The effect of hemodialysis on electrolytes and acid-base parameters. Clin. Chim. Acta 336:109–113 (2003).
  29. B. Canaud. Adequacy target in hemodialysis. J. Nephrol. 17:77–86 (2004).
  30. R. van der Geest, M. Danhof, and H. Boddé. Validation and testing of a new iontophoretic continuous flow through transport cell. J. Control. Release 51:85–91 (1998).
  31. P. F. Mulvenna and G. Savidge. A modified manual method for the determination of urea in seawater using diacetylmonoxime reagent. Estuar., Coast. Shelf Sci. 34:429–438 (1992).
  32. E. Rozet, V. Wascotte, N. Lecouturier, V. Préat, W. Dewé, B. Boulanger, and P. Hubert. Improvement of the decision efficiency of the accuracy profile by means of indexes for analytical methods validation. Application to a diacetyl-monoxime colorimetric assay used for the determination of urea in transdermal iontophoretic extracts. Anal. Chim. Acta (2006).
  33. C. R. Harding. The stratum corneum: structure and function in health and disease. Dermatol. Ther. 17(Suppl 1):6–15 (2004).
  34. M. Loden. Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. Am. J. Clin. Dermatol. 4:771–788 (2003).
  35. B. Mudry, R. H. Guy, and M. B. Delgado-Charro. Electromigration of ions across the skin: determination and prediction of transport numbers. J. Pharm. Sci., 95:561–569(2006).